Wilms' tumour gene 1 (WT1) in human neoplasia
Open Access
- 26 May 2005
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 19 (8) , 1318-1323
- https://doi.org/10.1038/sj.leu.2403817
Abstract
The transcription factor Wilms' tumour gene 1 (WT1) is important as a prognostic marker as well as in the detection and monitoring of minimal residual disease in leukaemia and myelodysplastic syndromes. Evidence has accumulated over the past decade to show that WT1 is a key molecule for tumour proliferation in a large number of human neoplasms most prominent in acute leukaemias, making it a suitable target for therapeutic strategies. Based on animal results, showing safety and efficacy of immunization with WT1 peptides and protein, early clinical trials in leukaemia have recently been initiated. The First International Conference on WT1 in Human Neoplasia was held in Berlin, March 11–12, 2004. This report reviews the current knowledge on the role of WT1 in tumour promotion and as a diagnostic and therapeutic target, and summarizes the data presented and discussed in this meeting.Keywords
This publication has 46 references indexed in Scilit:
- WT1 as a Universal Marker for Minimal Residual Disease Detection and Quantification in Myeloid Leukemias and in Myelodysplastic SyndromeActa Haematologica, 2004
- WT1 and glomerular functionSeminars in Cell & Developmental Biology, 2003
- The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemiaBlood, 2003
- Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patientsLeukemia, 2002
- Overexpression of the Wilms' tumor gene WT1 in de novo lung cancersInternational Journal of Cancer, 2002
- Cancer Immunotherapy Targeting Wilms’ Tumor Gene WT1 ProductThe Journal of Immunology, 2000
- GATA-1 Transactivates the WT1 Hematopoietic Specific EnhancerJournal of Biological Chemistry, 1995
- An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumorCell, 1990
- Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor geneCell, 1990
- Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locusCell, 1990